Delivery Order 75N93018D00001-75N93021F00006

Award Date 7/27/21
Potential Completion Date 6/2/25
Potential Value $635K
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
West Menlo Park, CA 94025, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $3,314,726 delivery order to Sri International, a non-profit research institute, to provide pre-clinical microbiological, safety, toxicology, and pharmacokinetic services. This order is part of the Nonclinical Services for Development of Interventional Agents indefinite delivery, indefinite quantity (IDIQ) contract. The period of performance runs through April...
This is a $5,310,519.00 delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to SRI International, a non-profit research institute, for nonclinical services to support the development of interventional agents for infectious diseases. The contract was issued under the "Nonclinical Services for Development of Interventional Agents" master IDIQ contract. The contract does not have a small business set-aside designation. SRI International has...
This is a cost-plus-fixed-fee delivery order awarded to SRI International, a nonprofit research and development institute, by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services (HHS). The $1,693,585.40 task order is for pre-clinical microbiological and safety studies and was issued under NIAID's Nonclinical Services for Development of Interventional Agents IDIQ contract. The award does not use a small business...
This is a $237,574 cost-plus-fixed-fee delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH), part of the Department of Health and Human Services (HHS). The contract is for the investigation and optimization of FG-960 preclinical formulations and was awarded to the non-profit research institute SRI International. The work will be performed in West Menlo Park, California. This delivery order falls under the larger...
This is a cost-plus-fixed-fee delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a part of the U.S. Department of Health and Human Services, to Sri International, a non-profit research and development institute. The contract, valued at $452,091.00, is for nonclinical services related to the development of interventional agents for infectious diseases. This award is part of a larger master indefinite delivery/indefinite quantity (IDIQ) contract...
This is a $117,119.24 cost-plus-fixed-fee delivery order contract awarded to Sri International, a non-profit research and development institute, by the National Institute of Allergy and Infectious Diseases (NIAID). The contract is for the process development and synthesis of 100 grams of ARN0075039, a non-GMP material. It is part of the "Nonclinical Services for Development of Interventional Agents" indefinite delivery, indefinite quantity (IDIQ) contract vehicle. The award has no...
This is a Cost Plus Fixed Fee delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to the non-profit research institute SRI International. The $3,919,858.62 task order is for a 39-week oral toxicology and toxicokinetic study in mature cynomolgus monkeys with the drug candidate PA-824, with a 12-week recovery period. This work falls under NIAID's broader "Preclinical Services for the Development...
This is a Delivery Order contract awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Sri International, a non-profit research institute, for Nonclinical Services for the Development of Interventional Agents for Infectious Diseases. The contract has a Firm Fixed Price type and a potential value of $157,734.00. It does not utilize any set-aside designation. The contract is under a larger Nonclinical Services for Development of...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $451,555 delivery order contract to Sri International under the master indefinite-delivery indefinite-quantity contract titled "Nonclinical Services for Development of Interventional Agents." The contract is for Sri International to provide nonclinical services for the development of interventional agents for infectious diseases from September 1,...
This is a Cost Plus Fixed Fee delivery order contract awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to SRI International, a non-profit research institute, for $122,706.00. The contract is for nonclinical services to support the development of interventional agents for infectious diseases. It is not associated with a larger contract vehicle and does not have a set-aside designation. SRI International has a history of providing a range...

This is a $381,002 delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to SRI International, a non-profit research institute. The contract is for Good Manufacturing Practice (GMP) manufacturing of the investigational drug oxfendazole for clinical trials, as well as conducting stability studies. The contract was awarded under the Nonclinical Services for Development of Interventional Agents indefinite delivery, indefinite quantity (IDIQ) contract vehicle. This contract has a ceiling value of $634,823 and a period of performance ending on June 2, 2025. The contract is a cost-plus-fixed-fee type and was not set aside for small businesses.

Generated 6/5/25, 10:13 AM